136 related articles for article (PubMed ID: 37632266)
1. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
[TBL] [Abstract][Full Text] [Related]
2. Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control.
Kopp-Schneider A; Calderazzo S; Wiesenfarth M
Biom J; 2020 Mar; 62(2):361-374. PubMed ID: 31265159
[TBL] [Abstract][Full Text] [Related]
3. Robust incorporation of historical information with known type I error rate inflation.
Calderazzo S; Wiesenfarth M; Kopp-Schneider A
Biom J; 2024 Jan; 66(1):e2200322. PubMed ID: 38063813
[TBL] [Abstract][Full Text] [Related]
4. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
Quan H; Zhang B; Lan Y; Luo X; Chen X
Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
[TBL] [Abstract][Full Text] [Related]
5. Conditional borrowing external data to establish a hybrid control arm in randomized clinical trials.
Li H; Tiwari R; Li QH
J Biopharm Stat; 2022 Nov; 32(6):954-968. PubMed ID: 35067183
[TBL] [Abstract][Full Text] [Related]
6. Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach.
Feißt M; Krisam J; Kieser M
Pharm Stat; 2020 Sep; 19(5):662-678. PubMed ID: 32227680
[TBL] [Abstract][Full Text] [Related]
7. Enhancing generalizability and efficiency in clinical trials through dynamic information borrowing for both experimental and control arms: A simulation study.
Yang J; Li G
J Evid Based Med; 2023 Dec; 16(4):547-556. PubMed ID: 38148281
[TBL] [Abstract][Full Text] [Related]
8. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
Harun N; Liu C; Kim MO
Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
[TBL] [Abstract][Full Text] [Related]
9. Use of historical control data for assessing treatment effects in clinical trials.
Viele K; Berry S; Neuenschwander B; Amzal B; Chen F; Enas N; Hobbs B; Ibrahim JG; Kinnersley N; Lindborg S; Micallef S; Roychoudhury S; Thompson L
Pharm Stat; 2014; 13(1):41-54. PubMed ID: 23913901
[TBL] [Abstract][Full Text] [Related]
10. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
Hupf B; Bunn V; Lin J; Dong C
Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
[TBL] [Abstract][Full Text] [Related]
11. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
Ji Z; Lin J; Lin J
J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
[TBL] [Abstract][Full Text] [Related]
12. Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.
Su L; Chen X; Zhang J; Yan F
JCO Precis Oncol; 2022 Mar; 6():e2100394. PubMed ID: 35263169
[TBL] [Abstract][Full Text] [Related]
13. A frequentist approach to dynamic borrowing.
Li R; Lin R; Huang J; Tian L; Zhu J
Biom J; 2023 Oct; 65(7):e2100406. PubMed ID: 37189217
[TBL] [Abstract][Full Text] [Related]
14. Elastic priors to dynamically borrow information from historical data in clinical trials.
Jiang L; Nie L; Yuan Y
Biometrics; 2023 Mar; 79(1):49-60. PubMed ID: 34437714
[TBL] [Abstract][Full Text] [Related]
15. Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowing.
Spanakis E; Kron M; Bereswill M; Mukhopadhyay S
J Biopharm Stat; 2023 Nov; 33(6):752-769. PubMed ID: 36507718
[TBL] [Abstract][Full Text] [Related]
16. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
Liu GF
Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
[TBL] [Abstract][Full Text] [Related]
17. BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints.
Bi D; Liu M; Lin J; Liu R
Stat Med; 2023 Dec; 42(30):5708-5722. PubMed ID: 37858287
[TBL] [Abstract][Full Text] [Related]
18. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
Chu Y; Yuan Y
Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
[TBL] [Abstract][Full Text] [Related]
19. Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations.
Tan WK; Segal BD; Curtis MD; Baxi SS; Capra WB; Garrett-Mayer E; Hobbs BP; Hong DS; Hubbard RA; Zhu J; Sarkar S; Samant M
Contemp Clin Trials Commun; 2022 Dec; 30():101000. PubMed ID: 36186544
[TBL] [Abstract][Full Text] [Related]
20. Empirical bayes approach for dynamic bayesian borrowing for clinical trials in rare diseases.
Sebastien B
J Pharmacokinet Pharmacodyn; 2023 Dec; 50(6):495-499. PubMed ID: 37148459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]